What Happened?
Chapel Hill, NC-based Bamboo-Therapeutics Appointed Sheila Mikhail as Chief Executive Officer
About the Company
Bamboo was formed to advance the work of Dr. Richard Jude Samulski, the Director of the Gene Therapy Center at the University of North Carolina (UNC), from the laboratory into human clinical trials where it could meet the requirements for drug approval. Dr. Samulski is a pioneer in the field of gene therapy. Over thirty (30) years ago, Dr. Samulski was the first person to realize the potential to use the adeno-associated virus (AAV) as a vehicle to replace a defective gene with a healthy gene. Since that time, he has re-engineered the naturally occurring virus to target delivery to certain tissues, de-target other tissues, and improve its safety. This has resulted in over twenty (20) patents related to the use of AAV for therapeutic uses. Dr. Samulski continues to lead innovation in the field of vector optimization and AAV re-engineering.
About the Person
Ms. Mikhail co-founded Bamboo in December 2014. She has been involved with three other gene therapy companies formed based on the work of Dr. Samulski. She was the Co-Founder and former CEO of Asklepios BioPharmaceutical, Inc. (AskBio), and was instrumental in the creation of Chatham Therapeutics, an affiliate of AskBio focused on the treatment of hemophilia (which was acquired by Baxter Healthcare in 2014). She was the Co-Founder and former CEO of NanoCor Therapeutics, a gene therapy company focused on the treatment of heart failure, and led its financing by Medtronic, Inc. Prior to Bamboo, Ms. Mikhail was the managing member of a boutique law firm focused on the needs of pharmaceutical and biotech companies. Sheila began her law career as a law clerk for the Honorable Martha Craig Daughtrey, 6th Circuit US Court of Appeals, and later, as an attorney with Ropes & Gray in Boston. Prior to law school, Ms. Mikhail worked as a management consultant for A.T. Kearney and Arthur Andersen in Chicago. Ms. Mikhail received a B.S., with highest honors, from the University of Illinois at Urbana-Champaign, a financing M.B.A, with honors from the University of Chicago, and a J.D. with honors, from Northwestern University.
Info Source
Press Release
Short Profile